Aequus Pharmaceuticals Inc (AQS) — Working Capital to Net Assets Ratio
Aequus Pharmaceuticals Inc (AQS) has a Working Capital to Net Assets ratio of 100.0% as of September 2025. Working capital of CA$-6.89 Million (current assets of CA$196.16K minus current liabilities of CA$7.09 Million) is measured against net assets of CA$-6.89 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Aequus Pharmaceuticals Inc to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Aequus Pharmaceuticals Inc Working Capital to Net Assets (2013–2024)
This chart shows how Aequus Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting working capital of CA$-6.89 Million against net assets of CA$-6.89 Million CAD. Check Aequus Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Aequus Pharmaceuticals Inc (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Aequus Pharmaceuticals Inc from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Aequus Pharmaceuticals Inc market cap and net worth.
| Year | WC/NA Ratio | Working Capital (CAD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 100.9% | CA$-6.51 Million | CA$-6.45 Million | CA$282.00K | CA$6.80 Million | ▼ -0.6 pp |
| 2023 | 101.6% | CA$-4.36 Million | CA$-4.29 Million | CA$435.61K | CA$4.80 Million | ▼ -5.3 pp |
| 2022 | 106.9% | CA$-1.48 Million | CA$-1.38 Million | CA$902.69K | CA$2.38 Million | ▲ +43.4 pp |
| 2021 | 63.5% | CA$1.14 Million | CA$1.79 Million | CA$3.59 Million | CA$2.46 Million | ▼ -351.9 pp |
| 2020 | 415.4% | CA$2.38 Million | CA$573.95K | CA$2.77 Million | CA$384.32K | ▲ +487.4 pp |
| 2019 | -72.0% | CA$631.69K | CA$-877.09K | CA$1.11 Million | CA$476.05K | ▼ -126.7 pp |
| 2018 | 54.7% | CA$920.17K | CA$1.68 Million | CA$1.24 Million | CA$314.90K | ▼ -3.8 pp |
| 2017 | 58.5% | CA$1.35 Million | CA$2.31 Million | CA$1.71 Million | CA$366.84K | ▲ +53.8 pp |
| 2016 | 4.7% | CA$59.14K | CA$1.27 Million | CA$803.55K | CA$744.41K | ▼ -14.0 pp |
| 2015 | 18.7% | CA$239.86K | CA$1.28 Million | CA$1.38 Million | CA$1.15 Million | ▼ -81.1 pp |
| 2014 | 99.8% | CA$2.92 Million | CA$2.92 Million | CA$3.66 Million | CA$744.51K | ▲ +2.2 pp |
| 2013 | 97.6% | CA$273.85K | CA$280.60K | CA$330.59K | CA$56.74K | — |